BIIB
NASDAQStockBiogen Inc.
$186.20-4.32 (-2.27%)
52-Week Range
$113.38
$201.18
Key Stats
Market Cap
27.3B
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.14
Volume
454.6K
Avg Volume
887.6K
Performance
1M
-3.29%
3M
+5.21%
6M
+29.01%
YTD
+3.98%
1Y
+32.09%
3Y
-29.52%
5Y
-28.92%
Price Chart
ETF Exposure
BIIB is held by 325 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| INRO | iShares U.S. Industry Rotation Active ETF | 0.02% |
| SCHZ | Schwab U.S. Aggregate Bond ETF | 0.02% |
| XCHG | Alliance Bernstein - AB US Equity ETF | 0.01% |
| EAOM | iShares ESG Aware 40/60 Moderate Allocation ETF | 0.01% |
| ITDG | iShares LifePath Target Date 2055 ETF | 0.01% |
| ITDH | iShares LifePath Target Date 2060 ETF | 0.01% |
| ITDI | iShares LifePath Target Date 2065 ETF | 0.01% |
| ITDJ | iShares LifePath Target Date 2070 ETF | 0.01% |
| AOA | iShares Core 80/20 Aggressive Allocation ETF | 0.01% |
| ITDF | iShares LifePath Target Date 2050 ETF | 0.01% |
| SPXL | Direxion Daily S&P 500 Bull 3X ETF | 0.01% |
| ITDE | iShares LifePath Target Date 2045 ETF | 0.01% |
| EAOK | iShares ESG Aware 30/70 Conservative Allocation ETF | 0.01% |
| ITDD | iShares LifePath Target Date 2040 ETF | 0.01% |
| AOR | iShares Core 60/40 Balanced Allocation ETF | 0.01% |
| ITDC | iShares LifePath Target Date 2035 ETF | 0.01% |
| AFTY | Pacer CSOP FTSE China A50 ETF | 0.01% |
| ITDB | iShares LifePath Target Date 2030 ETF | 0.01% |
| AOM | iShares Core 40/60 Moderate Allocation ETF | 0.01% |
| AVTM | Avantis Total Equity Markets ETF 1 | 0.01% |
| IRTR | iShares LifePath Retirement ETF | 0.01% |
| AOK | iShares Core 30/70 Conservative Allocation ETF | 0.00% |
| GTPE | Goldman Sachs MSCI World Private Equity Return Tracker ETF | 0.00% |
| LVHB | Innovator Laddered Allocation Power Buffer ETF | 0.00% |
| CHEP | AGFiQ U.S. Market Neutral Value Fund | 0.00% |
PreviousPage 7 of 7
About BIIB ETF Exposure
Biogen Inc. (BIIB) is held by 325 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 27.3B, BIIB is a widely held institutional stock. The stock currently trades at $186.20. Investors can gain exposure to BIIB through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold BIIB, sorted by portfolio weight.